接受化疗的乙肝表面抗原携带者乳腺癌患者的拉米夫定治疗：预防性还是先发制人？ - Suppr | 超能文献

Lamivudine therapy in HBsAg-carrying breast cancer patients undergoing chemotherapy: prophylactic or preemptive?

作者信息

Dai Ming-Shen, Chao Tsu-Yi

出版信息

Breast Cancer Res Treat. 2005 Jul;92(1):95-6. doi: 10.1007/s10549-005-1942-y.

DOI:10.1007/s10549-005-1942-y

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Lamivudine therapy in HBsAg-carrying breast cancer patients undergoing chemotherapy: prophylactic or preemptive?接受化疗的乙肝表面抗原携带者乳腺癌患者的拉米夫定治疗：预防性还是先发制人？

Breast Cancer Res Treat. 2005 Jul;92(1):95-6. doi: 10.1007/s10549-005-1942-y.

2

A single-center, prospective and randomized controlled study: Can the prophylactic use of lamivudine prevent hepatitis B virus reactivation in hepatitis B s-antigen seropositive breast cancer patients during chemotherapy?一项单中心、前瞻性、随机对照研究：预防性使用拉米夫定能否预防乙肝表面抗原阳性乳腺癌患者化疗期间乙型肝炎病毒再激活？

Breast Cancer Res Treat. 2011 Jun;127(3):705-12. doi: 10.1007/s10549-011-1455-9. Epub 2011 Mar 29.

3

Lamivudine for the prevention of hepatitis B virus reactivation after high-dose chemotherapy and autologous hematopoietic stem cell transplantation for patients with advanced or relapsed non-Hodgkin's lymphoma single institution experience.拉米夫定预防晚期或复发非霍奇金淋巴瘤患者大剂量化疗及自体造血干细胞移植后乙肝病毒再激活：单中心经验

Expert Opin Pharmacother. 2009 Oct;10(15):2399-406. doi: 10.1517/14656560903251710.

4

Hepatitis B virus reactivation in patients receiving chemotherapy for cancer treatment: role of Lamivudine prophylaxis.接受癌症化疗患者的乙型肝炎病毒再激活：拉米夫定预防的作用

Cancer Invest. 2006 Aug-Sep;24(5):548-52. doi: 10.1080/07357900600815232.

5

[Preventive effect of entecavir on hepatitis B flare up in HBsAg(+) breast cancer patients receiving chemotherapy].恩替卡韦对接受化疗的HBsAg（+）乳腺癌患者乙肝复发的预防作用

Zhonghua Gan Zang Bing Za Zhi. 2010 Jun;18(6):472-3. doi: 10.3760/cma.j.issn.1007-3418.2010.06.019.

6

Lamivudine therapy in kidney allograft recipients who are seropositive for hepatitis B surface antigen.对乙肝表面抗原血清学阳性的肾移植受者进行拉米夫定治疗。

Transplant Proc. 2006 Mar;38(2):496-8. doi: 10.1016/j.transproceed.2005.12.047.

7

Hepatitis B reactivation in a hepatitis B surface antigen-negative patient after allogeneic bone marrow transplant: successful treatment with lamivudine and seroconversion.异基因骨髓移植后乙肝表面抗原阴性患者的乙肝再激活：拉米夫定成功治疗及血清学转换

Diagn Microbiol Infect Dis. 2009 May;64(1):80-2. doi: 10.1016/j.diagmicrobio.2009.01.007. Epub 2009 Mar 21.

8

Severe reactivation of hepatitis B virus infection in a patient with hairy cell leukemia: Should lamivudine prophylaxis be recommended to HBsAg-negative, anti-HBc-positive patients?

Infection. 2006 Oct;34(5):282-4. doi: 10.1007/s15010-006-4150-8.

9

Prophylactic Effect of Lamivudine for Chemotherapy-Induced Hepatitis B Reactivation in Breast Cancer: A Meta-Analysis.拉米夫定对乳腺癌化疗所致乙型肝炎病毒再激活的预防作用：一项Meta分析

PLoS One. 2015 Jun 9;10(6):e0128673. doi: 10.1371/journal.pone.0128673. eCollection 2015.

10

Loss of hepatitis B surface antigen from the serum of patients with chronic hepatitis treated with lamivudine.接受拉米夫定治疗的慢性肝炎患者血清中乙肝表面抗原的消失。

J Med Virol. 2007 Oct;79(10):1472-7. doi: 10.1002/jmv.20994.

引用本文的文献

1

Prophylactic Lamivudine to Improve the Outcome of Breast Cancer Patients With HBsAg Positive During Chemotherapy: A Meta-Analysis.预防性使用拉米夫定改善化疗期间HBsAg阳性乳腺癌患者的预后：一项荟萃分析。

Hepat Mon. 2013 Apr 1;13(4):e6496. doi: 10.5812/hepatmon.6496. Print 2013 Apr.

2

Preventing chemotherapy-induced hepatitis B reactivation in breast cancer patients: a prospective comparison of prophylactic versus deferred preemptive lamivudine.预防乳腺癌患者化疗诱导的乙型肝炎病毒再激活：预防性与延迟性抢先拉米夫定的前瞻性比较。

Support Care Cancer. 2011 Nov;19(11):1779-87. doi: 10.1007/s00520-010-1019-2. Epub 2010 Oct 7.

3

Hepatitis B reactivation during adjuvant anthracycline-based chemotherapy in patients with breast cancer: a single institution's experience.乳腺癌患者在基于蒽环类药物的辅助化疗期间的乙肝再激活：单机构经验

Korean J Intern Med. 2007 Dec;22(4):237-43. doi: 10.3904/kjim.2007.22.4.237.